5G remote robot-assisted thoracoscopic lobectomy/segmentectomy for ten patients
- VernacularTitle:5G远程机器人辅助胸腔镜下解剖性肺叶/肺段切除术10例
- Author:
Fan SHEN
1
;
Jia HUANG
1
;
Yu TIAN
1
;
Hanbo PAN
1
;
Jiantao LI
1
;
Long JIANG
1
;
Hong GUO
2
;
Bentong YU
3
;
Qingquan LUO
1
Author Information
1. Department of Oncologic Surgery of Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China
2. Department of Thoracic Surgery of Affiliated Hospital of Yangzhou University, Yangzhou, 225000, Jiangshu, P. R. China
3. Department of Thoracic Surgery of the First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, P. R. China
- Publication Type:Journal Article
- Keywords:
Telesurgery;
robot-assisted surgery;
lobectomy/segmentectomy;
perioperative outcome
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2026;33(06):908-912
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the safety and feasibility of 5G remote robot-assisted thoracoscopic anatomic lobectomy and segmentectomy. Methods A retrospective analysis was conducted on patients who underwent 5G remote robot-assisted thoracoscopic anatomic lobectomy or segmentectomy between July and September 2024. The surgeries were performed collaboratively by Shanghai Chest Hospital, Affiliated Hospital of Yangzhou University, and The First Affiliated Hospital of Nanchang University. Perioperative outcomes were recorded and analyzed. Results Ten patients were included, comprising 4 anatomic lobectomies and 6 segmentectomies. The median age was 61.0 (56.0, 72.0) years. The median intraoperative bi-directional network latency was 52.5 (39.0, 54.0) ms. There were no instances of network interruption, robot-related adverse events, or conversions to open thoracotomy. The median postoperative chest tube drainage volume was 500.0 (375.0, 600.0) mL, and the median hospital stay was 5.5 (4.0, 6.0) days. No complications of Clavien-Dindo grade Ⅱor higher occurred. All patients were recurrence-free and alive during the 6-month postoperative follow-up period. Conclusion 5G remote robot-assisted thoracoscopic surgery demonstrates high safety and operational stability. This technology shows promising potential for clinical application and is worthy of further development and utilization.
